Sanofi/Ad Scientiam presented an interim analysis from the ongoing MS-DETECT (NCT05816122) study, showing that Microsoft (MS) ...
The US Supreme Court on Tuesday rejected President Donald Trump's bid to restrict birthright citizenship in a blow to one of ...
Ascendis Pharma A/S (Nasdaq: ASND) today announced that the latest data from its clinical development programs for the treatment of children with achondroplasia will be shared in an oral presentation ...
The court, in an eagerly awaited decision on the final day of its term, ruled 6-3 to maintain the right to American ...
Replimune Group, Inc. nears a pivotal FDA AdCom for RP1 ahead of an Aug 2, 2026 decision. Click for this REPLY stock update ...
Vaxart is developing game-changing oral vaccines with the potential to redefine vaccine delivery and immune responses: Vaxart is advancing multiple vaccine programs across high-value markets, ...
Free Malaysia Today on MSN
US Supreme Court rejects Trump’s bid to restrict birthright citizenship
US president Donald Trump’s bid to end birthright citizenship is part of his wider campaign to restrict immigration, ...
This statistical finding supports a lower liver-weight signal after adjustment for body fat percentage, suggesting the ...
The US Supreme Court on Tuesday rejected US President Donald Trump's bid to restrict birthright citizenship, in a ...
Studies released in recent weeks are fueling optimism — and fresh questions — about GLP-1 drugs' potential role in cancer prevention and treatment.
Mike O’Brien has a couple of memorable stories stretching from early in his childhood to just a month or so ago that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results